Bill Ackman has looked to legendary investor Warren Buffett as a model for Pershing Square, with large, long-term investments in a concentrated group of companies. The firm's IPO could mark Ackman's ...

Feb 19 (Reuters) - Wall Street broker Clear Street on Thursday pulled its U.S. listing plan a week after delaying it, as heightened worries over AI-related disruptions spilled over to the new listings ...

The Japanese payments fintech PayPay has announced its long-awaited U.S. initial public offering. Processing Content The mobile payments app made public its F-1 prospectus filing with the Securities ...

With news that Discord is kicking the tires on going public soon, other tech companies are starting to take their chances. Liftoff Mobile filed its first S-1 document late Tuesday, the first step in ...

Eikon Therapeutics, Inc. (EIKN) has filed to raise development capital in an IPO of its common stock, according to SEC S-1 registration information. The company is a large biopharma firm developing ...

After a lackluster 2024, initial public offerings roared back to life in 2025. IPO research and investment manager Renaissance Capital says 202 companies priced IPOs in 2025, a 35% increase from 2024, ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Eikon's leadership team includes ...

Andersen Group ANDG-7.92%decrease; red down pointing triangle is a publicly held company now, two decades after the criminal conviction of its namesake accounting firm, Arthur Andersen, was overturned ...

Kraken’s pending IPO and the wave of crypto companies seeking public listings may help the industry attract more TradFi capital. A potential initial public offering (IPO) next year by cryptocurrency ...

Medline shares surged more than 40% in their hotly anticipated New York debut on Wednesday, valuing the medical supply giant at $54 billion in the largest US initial public offering since Rivian’s ...

Starton Holdings, Inc. (STA) has filed to raise $40 million in an IPO of its common stock, according to SEC S-1 registration information. The firm is a clinical-stage biopharma developing drug ...